What is the EV/FCF ratio for Pacific Biosciences of California, Inc. (PACB)?

The EV/FCF ratio for PACB stock is N/A.

What is the estimated TTM average EV/FCF ratio for Pacific Biosciences of California, Inc. (PACB)?

The estimated TTM average EV/FCF ratio for PACB stock is 197.16x.

Pacific Biosciences of California (PACB) EV/FCF: History & Chart

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T18:52:37.487Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:52:37.487Z.

Quote observation: 2026-10-06T18:50:10.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 849,495,617
Total debt · period ending 2026-06-30: 706,127,000
Cash · period ending 2026-06-30: 61,003,000
TTM free cash flow · period ending 2026-06-30: -171,329,000

FMP input reference: 6b7402e8e4aad00529a5dc64304a2ec9485b3d7feb734bca750ca78a67bf3000

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

PACB EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

EV/FCF RATIO AVG TTM

197.16x

EV/FCF RATIO AVG 3Y

N/A

EV/FCF RATIO AVG 5Y

N/A

EV/FCF RATIO AVG 10Y

N/A

EV/FCF RATIO AVG 15Y

N/A

EV/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

PACB Competitors' EV/FCF Ratio

PACB

Pacific Biosciences of California, Inc.

Current

Market Cap

$849.50M

EV/FCF Ratio

N/A

TTM Avg

197.16x

3Y Avg

N/A

5Y Avg

N/A

QDEL

QuidelOrtho Corporation

vs PACB

Market Cap

$846.74M

EV/FCF Ratio

N/A

TTM Avg

241.82x

3Y Avg

97.19x

5Y Avg

51.67x

SIBN

SI-BONE, Inc.

vs PACB

Market Cap

$856.66M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SLBT

SL Science Holding Ltd

vs PACB

Market Cap

$857.96M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SGP

SpyGlass Pharma, Inc. Common Stock

vs PACB

Market Cap

$840.88M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALMS

Alumis Inc.

vs PACB

Market Cap

$838.44M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BBNX

Beta Bionics, Inc.

vs PACB

Market Cap

$840.86M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RIGL

Rigel Pharmaceuticals, Inc.

vs PACB

Market Cap

$863.59M

EV/FCF Ratio

10.62x

TTM Avg

9.71x

3Y Avg

14.43x

5Y Avg

26.15x

GLUE

Monte Rosa Therapeutics, Inc.

vs PACB

Market Cap

$834.23M

EV/FCF Ratio

N/A

TTM Avg

10.33x

3Y Avg

10.33x

5Y Avg

10.33x

CRVS

Corvus Pharmaceuticals, Inc.

vs PACB

Market Cap

$882.40M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
Pacific Biosciences of California, Inc. (PACB)	$849.50M	N/A	197.16x	N/A	N/A
QuidelOrtho Corporation (QDEL)vs ›	$846.74M	N/A	241.82x	97.19x	51.67x
SI-BONE, Inc. (SIBN)vs ›	$856.66M	N/A	N/A	N/A	N/A
SL Science Holding Ltd (SLBT)vs ›	$857.96M	N/A	N/A	N/A	N/A
SpyGlass Pharma, Inc. Common Stock (SGP)vs ›	$840.88M	N/A	N/A	N/A	N/A
Alumis Inc. (ALMS)vs ›	$838.44M	N/A	N/A	N/A	N/A
Beta Bionics, Inc. (BBNX)vs ›	$840.86M	N/A	N/A	N/A	N/A
Rigel Pharmaceuticals, Inc. (RIGL)vs ›	$863.59M	10.62x	9.71x	14.43x	26.15x
Monte Rosa Therapeutics, Inc. (GLUE)vs ›	$834.23M	N/A	10.33x	10.33x	10.33x
Corvus Pharmaceuticals, Inc. (CRVS)vs ›	$882.40M	N/A	N/A	N/A	N/A

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio FAQ

What is the EV/FCF ratio for Pacific Biosciences of California, Inc. (PACB)?: The EV/FCF ratio for PACB stock is N/A.
What is the estimated TTM average EV/FCF ratio for Pacific Biosciences of California, Inc. (PACB)?: The estimated TTM average EV/FCF ratio for PACB stock is 197.16x.

PACB EV/FCF Ratio History

DATE	EV/FCF RATIO
2021-05-06	266.76x
2021-05-05	273.16x
2021-05-04	278.90x
2021-05-03	298.89x
2021-04-30	327.37x
2021-04-29	367.44x
2021-04-28	369.09x
2021-04-27	369.20x
2021-04-26	358.05x
2021-04-23	339.62x
2021-04-22	334.32x
2021-04-21	331.56x
2021-04-20	319.09x
2021-04-19	324.72x
2021-04-16	345.91x
2021-04-15	360.48x
2021-04-14	357.17x
2021-04-13	365.73x
2021-04-12	337.19x
2021-04-09	352.87x
2021-04-08	367.55x
2021-04-07	357.17x
2021-04-06	389.74x
2021-04-05	379.03x
2021-04-01	371.19x
2021-03-31	365.56x
2021-03-30	328.47x
2021-03-29	313.90x
2021-03-26	337.08x
2021-03-25	334.98x
2021-03-24	324.94x
2021-03-23	358.38x
2021-03-22	381.90x
2021-03-19	366.88x
2021-03-18	349.66x
2021-03-17	382.34x
2021-03-16	367.00x
2021-03-15	387.20x
2021-03-12	371.96x
2021-03-11	389.74x
2021-03-10	351.98x
2021-03-09	344.25x
2021-03-08	299.99x
2021-03-05	320.96x
2021-03-04	315.55x
2021-03-03	339.67x
2021-03-02	376.93x
2021-03-01	386.64x
2021-02-26	350.65x
2021-02-25	357.62x
2021-02-24	410.37x
2021-02-23	426.17x
2021-02-22	429.86x
2021-02-19	494.30x
2021-02-18	490.96x
2021-02-17	507.45x
2021-02-16	532.81x
2021-02-12	578.35x
2021-02-11	587.92x
2021-02-10	527.39x
2021-02-09	454.07x
2021-02-08	443.81x
2021-02-05	415.79x
2021-02-04	401.84x
2021-02-03	399.65x
2021-02-02	404.55x
2021-02-01	392.27x
2021-01-29	371.17x
2021-01-28	393.42x
2021-01-27	356.30x
2021-01-26	377.28x
2021-01-25	412.68x
2021-01-22	429.62x
2021-01-21	416.83x
2021-01-20	443.06x
2021-01-19	461.68x
2021-01-15	423.92x
2021-01-14	433.08x
2021-01-13	394.23x
2021-01-12	381.38x
2021-01-11	393.19x
2021-01-08	421.32x
2021-01-07	377.40x
2021-01-06	324.48x
2021-01-05	321.13x
2021-01-04	302.28x
2020-12-31	297.27x
2020-12-30	302.00x
2020-12-29	290.81x
2020-12-28	313.41x
2020-12-24	310.99x
2020-12-23	326.78x
2020-12-22	308.91x
2020-12-21	263.83x
2020-12-18	229.94x
2020-12-17	228.79x
2020-12-16	236.74x
2020-12-15	237.32x
2020-12-14	239.16x
2020-12-11	241.99x
2020-12-10	251.15x
2020-12-09	240.20x
2020-12-08	257.84x
2020-12-07	246.08x
2020-12-04	230.86x
2020-12-03	216.68x
2020-12-02	205.73x
2020-12-01	205.15x
2020-11-30	180.48x
2020-11-27	176.10x
2020-11-25	165.84x
2020-11-24	164.34x
2020-11-23	170.33x
2020-11-20	172.06x
2020-11-19	175.18x
2020-11-18	175.06x
2020-11-17	173.91x
2020-11-16	178.06x
2020-11-13	191.20x
2020-11-12	191.03x
2020-11-11	188.09x
2020-11-10	167.22x
2020-11-09	169.41x
2020-11-06	164.22x
2020-11-05	156.73x
2020-11-04	141.16x
2020-11-03	144.74x
2020-11-02	138.74x
2020-10-30	137.28x
2020-10-29	139.89x
2020-10-28	146.28x
2020-10-27	153.29x
2020-10-26	146.07x
2020-10-23	145.55x
2020-10-22	144.24x
2020-10-21	137.07x
2020-10-20	142.20x
2020-10-19	156.54x
2020-10-16	150.47x
2020-10-15	150.15x
2020-10-14	146.17x
2020-10-13	146.07x
2020-10-12	137.38x
2020-10-09	141.36x
2020-10-08	133.30x
2020-10-07	128.07x
2020-10-06	127.44x
2020-10-05	133.40x
2020-10-02	122.62x
2020-10-01	109.96x
2020-09-30	103.36x
2020-09-29	102.63x
2020-09-28	100.53x
2020-09-25	96.87x
2020-09-24	93.31x
2020-09-23	89.02x
2020-09-22	92.00x
2020-09-21	87.35x
2020-09-18	85.15x
2020-09-17	81.80x
2020-09-16	82.43x
2020-09-15	76.67x
2020-09-14	76.14x
2020-09-11	74.16x
2020-09-10	73.00x
2020-09-09	71.02x
2020-09-08	68.19x
2020-09-04	67.77x
2020-09-03	66.51x
2020-09-02	72.27x
2020-09-01	74.31x
2020-08-31	69.13x
2020-08-28	67.14x
2020-08-27	66.20x
2020-08-26	68.71x
2020-08-25	67.56x
2020-08-24	69.76x
2020-08-21	68.61x
2020-08-20	67.77x
2020-08-19	67.98x
2020-08-18	65.36x
2020-08-17	64.21x
2020-08-14	60.23x
2020-08-13	58.77x
2020-08-12	57.83x
2020-08-11	46.83x
2020-08-10	49.35x
2020-08-07	49.56x
2020-08-06	29.61x
2020-08-05	28.40x
2020-08-04	28.18x
2020-08-03	28.33x
2020-07-31	26.97x
2020-07-30	27.27x
2020-07-29	27.88x
2020-07-28	27.27x
2020-07-27	27.35x
2020-07-24	26.29x
2020-07-23	28.40x
2020-07-22	28.63x
2020-07-21	29.69x
2020-07-20	30.63x
2020-07-17	30.48x
2020-07-16	29.99x
2020-07-15	30.29x
2020-07-14	28.25x
2020-07-13	27.42x
2020-07-10	26.86x
2020-07-09	27.80x
2020-07-08	27.65x
2020-07-07	27.42x
2020-07-06	28.48x
2020-07-02	27.05x
2020-07-01	26.03x
2020-06-30	24.86x
2020-06-29	24.86x
2020-06-26	24.33x
2020-06-25	25.61x
2020-06-24	25.54x
2020-06-23	26.75x
2020-06-22	25.69x
2020-06-19	25.31x
2020-06-18	26.67x
2020-06-17	26.97x
2020-06-16	26.75x
2020-06-15	26.75x
2020-06-12	25.77x
2020-06-11	24.03x
2020-06-10	26.67x
2020-06-09	29.16x
2020-06-08	28.25x
2020-06-05	29.23x
2020-06-04	27.20x
2020-06-03	27.12x
2020-06-02	26.59x
2020-06-01	25.61x
2020-05-29	25.39x
2020-05-28	25.61x
2020-05-27	26.71x
2020-05-26	26.03x
2020-05-22	25.39x
2020-05-21	26.90x
2020-05-20	26.22x
2020-05-19	25.92x
2020-05-18	25.88x
2020-05-15	25.09x
2020-05-14	25.16x
2020-05-13	25.31x
2020-05-12	25.39x
2020-05-11	25.61x

EV/FCF Ratio: N/A

PACB EV/FCF Ratio Chart

PACB Average EV/FCF Ratio Chart

PACB EV/FCF Ratio Metrics

PACB Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

EV/FCF Ratio FAQ

PACB EV/FCF Ratio History

Related Metrics